Capturing valuable information from the human placenta after the birth of a child can be as simple as snapping a few smart phone pictures, researchers say.
Alison D. Gernand, associate professor at Penn State University’s College of Human Development, is developing a software program that analyzes pictures of the temporary organ for abnormalities such as infection or lesions. The pictures can be taken with a smart phone.
UPMC Magee-Womens Hospital was among the hospitals where images of the nutrient-rich organ, usually weighing a little more than a pound and expelled as afterbirth, were taken for Ms. Gernand’s studies. The new device is called PlacentaVision and it uses computer vision and artificial intelligence to identify abnormalities that may one day help predict future health issues for mothers and their newborns.
“Most people are not looking at the placenta,” she said. “We’re trying to make it easy. It needs to be part of clinical care because it can be so informative. Our goal is to create a mobile app to interact with the camera.”
PlacentaVision is artificial intelligence’s latest application in medicine, which in Pittsburgh has included such things as ambient listening devices that convert doctor-patient conversations into medical records, easing an administrative burden for physicians. AI is poised to revolutionize medicine by analyzing vast amounts of data and developing treatment plans to fit the individual rather than a population, which is now the standard of care.
A new Congressional Budget Office report took a cautious approach in forecasting AI’s impact on business development and medicine.
Read More
“By increasing efficiency, enabling the development of new products, and altering the demand for workers, AI has the potential to change the economy, perhaps in ways that are difficult to predict,” the report found. “Whether or when those changes might occur is very uncertain. Surveys show that only 5% of businesses in the United States currently rely on AI to produce goods and services.”
Ms. Gernand’s goal is to commercialize an easy-to-use, low-cost product that would be available in every hospital with a maternity unit. Such a product will need Food & Drug Administration approval, she said.
Today, only about 20% of placentas are sent to hospital pathology labs, Ms. Gernand said, which means “basically we have almost no information on placentas for most births.” This is unfortunate because some studies have linked placenta insights to cardiovascular disease and diabetes in later life for the mom, opening the door to early intervention.
At issue is time and expense of preparing a conventional pathology report on the placenta, with the results often only becoming available after mom and baby have gone home from the hospital.
“When the neonatal intensive care unit is treating a sick kid, even a few minutes can make a difference in medical decision making,” Jeffrey Goldstein, director of perinatal pathology at Northwestern University Feinberg School of Medicine, said in a prepared statement. “With a diagnosis from these photographs, we can have an answer days earlier than we would in our normal process.”
Northwestern provided the largest set of placental images for a study of the procedure that was published Dec. 13 and authored by Ms. Gernand and Dr. Goldstein, who led development of the algorithms used by the AI software.
Researchers used an AI method for aligning and understanding the relationship between different types of data — visual images and textual pathological reports — to teach a computer program how to analyze pictures of placentas. More than 31,700 placental images and pathological reports spanning a 12-year-period from hospitals in the U.S. and Uganda were analyzed for connections to health outcomes in moms and babies.
“The placenta is the most important part of pregnancy,” Ms. Gernand said. “It’s really doing everything, transferring hormones to mom and baby. There’s really a whole world to unlock here.”






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.